首页> 外文期刊>Human Genetics >Heterogeneous mutations in the glycogen-debranching enzyme gene are responsible for glycogen storage disease type IIIa in Japan.
【24h】

Heterogeneous mutations in the glycogen-debranching enzyme gene are responsible for glycogen storage disease type IIIa in Japan.

机译:糖原解支酶基因中的异质突变是造成日本糖原贮积病IIIa型的原因。

获取原文
获取原文并翻译 | 示例
           

摘要

Glycogen storage disease type IIIa (GSD IIIa) is an autosomal recessive disorder caused by deficiency of the glycogen-debranching enzyme (AGL). Recent studies of the AGL gene have revealed the prevalent mutations in North African Jewish and Caucasian populations, but whether these common mutations are present in other ethnic groups remains unclear. We have investigated eight Japanese GSD IIIa patients from seven families and identified seven mutations, including one splicing mutation (IVS 14+1G-->T) previously reported by us, together with six novel ones: a nonsense mutation (L124X), a splice site mutation (IVS29-1G-->C), a 1-bp deletion (587delC), a 2-bp deletion (4216-4217delAG), a 1-bp insertion (2072-2073insA), and a 3-bp insertion (4735-4736insTAT). The last mutation results in insertion of a tyrosine residue at a putative glycogen-binding site, and the rest are predicted to cause synthesis of truncated proteins lacking the glycogen-binding site at the carboxyl terminal. Thirteen novel polymorphisms have also been revealed in this study: three amino acid substitutions (R387Q, G1115R, and E1343 K), one silent point mutation (L298L), one nucleotide change in the 5'-noncoding region, and eight nucleotide changes in introns. Haplotype analysis with combinations of these polymorphic markers showed L124X, IVS14+1G-->T, and 4216-4217delAG to be on different haplotypes. These results demonstrate the importance of the integrity of the carboxy terminal domain in the AGL protein and the molecular heterogeneity of GSD IIIa in Japan.
机译:糖原贮积病IIIa型(GSD IIIa)是由糖原解支酶(AGL)缺乏引起的常染色体隐性遗传疾病。最近对AGL基因的研究揭示了北非犹太人和高加索人群中普遍存在的突变,但尚不清楚这些常见突变是否存在于其他种族中。我们调查了来自七个家庭的八名日本GSD IIIa患者,发现了七个突变,包括我们先前报道的一个剪接突变(IVS 14 + 1G-> T),以及六个新突变:一个无意义的突变(L124X),一个剪接位点突变(IVS29-1G-> C),1 bp缺失(587delC),2 bp缺失(4216-4217delAG),1 bp插入(2072-2073insA)和3 bp插入( 4735-4736insTAT)。最后一个突变导致酪氨酸残基插入一个假定的糖原结合位点,其余突变预计会导致在羧基末端缺少糖原结合位点的截短蛋白的合成。这项研究还揭示了13种新的多态性:三个氨基酸取代(R387Q,G1115R和E1343 K),一个沉默点突变(L298L),一个5'非编码区核苷酸变化和一个内含子八个核苷酸变化。 。结合这些多态性标记的单倍型分析显示L124X,IVS14 + 1G-> T和4216-4217delAG具有不同的单倍型。这些结果证明了在日本AGL蛋白中羧基末端结构域的完整性和GSD IIIa分子异质性的重要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号